Form 8-K - Current report:
SEC Accession No. 0001213900-15-005229
Filing Date
2015-07-16
Accepted
2015-07-16 09:01:31
Documents
5
Period of Report
2015-07-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k071415_relmadatherap.htm 8-K 32261
2 DIRECTOR AGREEMENT f8k071415ex10i_relmadatherap.htm EX-10.1 23957
3 DIRECTOR INDEMNITY AGREEMENT f8k071415ex10ii_relmadather.htm EX-10.2 78322
4 PRESS RELEASE f8k071415ex99i_relmadather.htm EX-99.1 12311
5 GRAPHIC image_001.jpg GRAPHIC 3897
  Complete submission text file 0001213900-15-005229.txt   153693
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55347 | Film No.: 15990611
SIC: 2834 Pharmaceutical Preparations